On May 31st, from 11h to 12h30 CET, EuropaBio – the European Association for Bioindustries, will host the first online round table discussion within its new SME BioForum. This online and invite-only meeting will focus on the business environment in Europe for Advanced Therapy Medicinal Products (ATMPs) in Europe. Selected SMEs are being invited by their biotechnology association which sits within EuropaBio.
The SME BioForum will bring together senior executives from Europe’s growing SMEs within ATMPs. The moderated discussion will address commercial development challenges and how the European regulatory and market access landscape influences their growth and delivery of products to patients.
From this BioForum, EuropaBio and its National Association Council will undertake direct advocacy on SME priorities to key stakeholders at the national and European levels to address the legislation, regulatory, finance and market access issues that impact SME competitiveness.
By participating in this BioForum, SME executives have their voices heard and represented at the highest levels in Europe.
Participants should be at senior management level, with the ability to debate their company’s challenges for sustainable growth to profit and current developments in their national biotechnology context within their field of expertise. There is no requirement for participants to be knowledgeable of or involved in policy efforts.
If you have any queries or wish for further details, please get in touch with José Peres at j.peres@europabio.org.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.